The FDA's regulations have inadvertently allowed pharmaceutical companies to market drugs more effectively by listing numerous side effects, which can dilute consumer perception of severity. Research shows that when more side effects are mentioned, even minor ones, patients rate the overall severity of the drug's side effects as less serious. This paradox highlights the importance of concise communication—sometimes, less truly is more.
